加味柴胡桂枝汤治疗气滞血瘀型冠心病稳定性心绞痛伴焦虑/抑郁的临床研究

Clinical Study of Modified Chaihu Guizhi Decoction in Treating Stable Angina Pectoris of Coronary Heart Disease with Anxiety/Depression of Qi Stagnation and Blood Stasis Type

  • 摘要:
      目的  观察加味柴胡桂枝汤治疗气滞血瘀型冠心病稳定性心绞痛伴焦虑/抑郁的临床疗效。
      方法  纳入气滞血瘀型冠心病稳定性心绞痛伴焦虑/抑郁患者60例, 随机分为对照组、治疗组各30例, 2组患者均予健康宣教、心理疏导及冠心病心绞痛常规治疗等基础治疗, 对照组加服氟哌噻吨美利曲辛片, 治疗组加服加味柴胡桂枝汤, 疗程均4周。治疗前后评估2组患者中医证候积分及疗效、心绞痛症状积分、心电图平板运动试验、硝酸甘油停减率、焦虑自评量表(SAS)、抑郁自评量表(SDS)及西雅图心绞痛调查量表(SAQ)评分, 检测血脂(TC、TG、LDL-C、HDL-C)及血清IL-6表达水平。
      结果  治疗后, 2组患者中医证候积分、心绞痛症状积分、SAS、SDS评分均显著降低(P < 0.01), SAQ各维度积分明显增加(P < 0.01), 平板运动试验ST段压低1 mm出现时间及心绞痛出现时间均显著延长(P < 0.01)、ST段恢复时间明显缩短(P < 0.01), TC、TG、LDL-C、IL-6水平均明显降低(P < 0.05, P < 0.01);且治疗组改善中医证候积分、心绞痛症状积分、SAS、SDS评分、SAQ中PL及TS积分、中医证候显效率、硝酸甘油停减率、血脂(TC、LDL-C)及血清IL-6均优于对照组(P < 0.05, P < 0.01)。
      结论  加味柴胡桂枝汤能明显改善气滞血瘀型冠心病稳定性心绞痛伴焦虑/抑郁患者临床症状、焦虑抑郁状态, 提高生存质量, 同时降低血脂及血清IL-6水平。

     

    Abstract:
      OBJECTIVE  To observe the clinical efficacy of modified Chaihu Guizhi Decoction in treating stable angina pectoris with anxiety/depression in patients with coronary heart disease of qi stagnation and blood stasis type.
      METHODS  60 patients with stable angina pectoris and anxiety/depression caused by qi stagnation and blood stasis type of coronary heart disease were included in the study. They were randomly divided into a control group (n=30) and a treatment group (n=30). Both groups of patients received health education, psychological counseling, and routine treatment for coronary heart disease angina pectoris. The control group received droperidol melitracin tablets in addition to basic treatment, while the treatment group received modified Chaihu Guizhi Decoction in addition to basic treatment for 4 weeks. The efficacy of traditional Chinese medicine (TCM) syndrome, total score of traditional Chinese medicine syndrome, angina symptom score, electrocardiogram treadmill exercise test, nitroglycerin withdrawal rate, self-rating anxiety scale (SAS), self-rating depression scale (SDS), and Seattle angina questionnaire (SAQ) scores between the two groups of patients were compared before and after treatment. At the same time, peripheral blood lipids and IL-6 levels were measured.
      RESULTS  After treatment, the TCM syndrome score, angina symptom score, SAS, SDS score of both groups of patients decreased (P < 0.01), and the scores of various dimensions of SAQ increased (P < 0.01). The occurrence time of ST segment depression of 1mm in treadmill exercise test was prolonged, the occurrence time of angina was prolonged, and the recovery time of ST segment was shortened (P < 0.01), and TC, TG, LDL-C, IL-6 were significantly reduced (P < 0.05, P < 0.01). Moreover, the treatment group was superior to the control group in improving TCM syndrome scores, angina symptom scores, SAS, SDS scores, PL and TS scores in SAQ, apparent effective rate of TCM syndrome, nitroglycerin cessation rate, blood lipids (TC, LDL-C), and serum IL-6 (P < 0.05, P < 0.01).
      CONCLUSION  Modified Chaihu Guizhi Decoction can significantly improve the clinical symptoms, anxiety and depression status of patients with stable angina pectoris and anxiety/depression of qi stagnation and blood stasis type of coronary heart disease, improve quality of life, reduce blood lipids and IL-6 levels.

     

/

返回文章
返回